FDA approves Juvmo (tavapadon) - FDA New Drug Approvals - Nundina

Nundina › Discover calendars › FDA New Drug Approvals calendar › FDA approves Juvmo (tavapadon)FDA approves Juvmo (tavapadon)25 September 2026The FDA approved Juvmo (tavapadon), a drug from Abbvie. Form: Tablet, Oral. Application NDA220415.FDA New Drug Approvals calendarMore from this calendar

19 October 2026 - FDA approves Calrezdy (calcuim chloride)

19 October 2026 - FDA approves Cienby (sodium ctirate)

16 October 2026 - FDA approves Yulzety (rivaroxaban)

16 October 2026 - FDA approves Brytly (brytly (apraclonidine))

15 October 2026 - FDA approves Evoxac (cevimeline hydrochloride)